Header Logo

Selectivity of (±)-citalopram at nicotinic acetylcholine receptors and different inhibitory mechanisms between habenular a3ß4* and a9a10 subtypes.

Arias HR, Jin XT, Gallino S, Peng C, Feuerbach D, García-Colunga J, Elgoyhen AB, Drenan RM, Ortells MO. Selectivity of (±)-citalopram at nicotinic acetylcholine receptors and different inhibitory mechanisms between habenular a3ß4* and a9a10 subtypes. Neurochem Int. 2019 12; 131:104552.

View in: PubMed